Your browser doesn't support javascript.
loading
Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV.
Fader, Lee D; Carson, Rebekah; Morin, Sébastien; Bilodeau, François; Chabot, Catherine; Halmos, Ted; Bailey, Murray D; Kawai, Stephen H; Coulombe, René; Laplante, Steven; Mekhssian, Kevork; Jakalian, Araz; Garneau, Michel; Duan, Jianmin; Mason, Stephen W; Simoneau, Bruno; Fenwick, Craig; Tsantrizos, Youla; Yoakim, Christiane.
Afiliação
  • Fader LD; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Carson R; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Morin S; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Bilodeau F; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Chabot C; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Halmos T; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Bailey MD; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Kawai SH; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Coulombe R; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Laplante S; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Mekhssian K; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Jakalian A; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Garneau M; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Duan J; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Mason SW; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Simoneau B; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Fenwick C; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Tsantrizos Y; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
  • Yoakim C; Research and Development, Boehringer Ingelheim (Canada), Ltd. , 2100 Cunard Street, Laval, Québec H7S 2G5, Canada.
ACS Med Chem Lett ; 5(6): 711-6, 2014 Jun 12.
Article em En | MEDLINE | ID: mdl-24944749
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Canadá